TrialInternational journal of chronic obstructive pulmonary disease2018

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.

James F Donohue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.